# Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/azienda-universitaria-ospedaliera-consorziale-policlinico-bari/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 55.1 |
| Citations | 64,021 |
| City | Bari |
| Country | IT |
| Description | Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari is a research organisation in Bari, IT. OpenAlex records 2,432 works and 64,021 citations for it. 753 researchers list it as their most recent affiliation. |
| Homepage | https://www.sanita.puglia.it/web/ospedalegiovannixxiii |
| OpenAlex ID | https://openalex.org/I4210095088 |
| Researchers | 753 |
| ROR ID | https://ror.org/00pap0267 |
| Type | healthcare |
| Works | 2,432 |

## University papers

Showing 12 of 37.

- [Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/)
- [Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-cell-carcinoma/)
- [Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-cabozantinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/)
- [Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial](https://scholariq.org/papers/once-weekly-tirzepatide-versus-once-daily-insulin-degludec-as-add-on-to/)
- [Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial](https://scholariq.org/papers/safety-and-efficacy-of-sunitinib-for-metastatic-renal-cell-carcinoma-an-expanded/)
- [Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up](https://scholariq.org/papers/renal-cell-carcinoma-esmo-clinical-practice-guideline-for-diagnosis-treatment/)
- [Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival](https://scholariq.org/papers/evaluation-of-clear-cell-papillary-and-chromophobe-renal-cell-carcinoma/)
- [Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial](https://scholariq.org/papers/effects-on-the-incidence-of-cardiovascular-events-of-the-addition-of/)
- [ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial](https://scholariq.org/papers/abvd-compared-with-beacopp-compared-with-cec-for-the-initial-treatment-of/)
- [Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)](https://scholariq.org/papers/efficacy-and-safety-of-once-weekly-dulaglutide-versus-insulin-glargine-in/)
- [Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis](https://scholariq.org/papers/efficacy-and-safety-of-very-low-calorie-ketogenic-diet-vlckd-in-patients-with/)
- [Continuous Subcutaneous Glucose Monitoring in Diabetic Patients](https://scholariq.org/papers/continuous-subcutaneous-glucose-monitoring-in-diabetic-patients/)

## University researchers

- [Gennaro Martines](https://scholariq.org/researchers/gennaro-martines/)
- [Francesco Gaudio](https://scholariq.org/researchers/francesco-gaudio/)

## University top topics

Showing 8 of 25.

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.